Latest immune response News

Malaria and immunology researchers win Burnet Prize
When there is good vaccine news – efficacy is only beginning of story
Expert commentary: Oxford and AstraZeneca vaccine preliminary Phase III data
Nanobodies could hold clues to new COVID-19 therapies
Study to determine cyclosporine’s role in treating hospitalized COVID-19 patients
Sustained COVID-19 immunity promising for vaccine effectiveness
Study reveals immune cells’ COVID memory
Sydney to undertake clinical studies of needle-free vaccine patch
Monash researchers reveal COVID immunity lasts up to eight months, giving hope for long-term protection by vaccines
$41.7 million boost to commercialise lifesaving medical discoveries
WEHI director named 2020 Melburnian of Year
Department of Defense funds development of a new Lyme disease vaccine
Altered ‘coat’ disguises fatal brain virus from neutralizing antibodies
Trial of Oxford coronavirus vaccine in Southampton shows strong immune response in older adults
Arthritis drug effective in treating sickest COVID-19 patients
Houston companies awarded top honors at premier life science venture capital conference
Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India
Baylor COVID-19 vaccine begins clinical trial in India
Southampton Professor to lead Janssen COVID-19 vaccine trial
Drug research pivoted from prostate cancer to COVID-19 treatment
Seqirus will build world-class, next-generation $800m influenza vaccine manufacturing facility in Australia
Ludwig Lausanne receives Team Science Award from Society for Immunotherapy of Cancer
Light, liposomes, action: researchers show safer, more targeted way to deliver CRISPR gene therapy
Uracil Switch in SARS-CoV-2 Genome Alters Innate Immune Responses
HRI expands research into inflammation and blood pressure disorders
That’s a Wrap: Protein ‘Burritos’ Stabilize Vaccines
Could SARS-CoV-2 evolve resistance to COVID-19 vaccines?
A better test for tumor-targeting of CAR-T therapies
Australia Secures a further 50 Million Doses of COVID-19 Vaccine
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
Teaming up: Coronavirus research at Cornell
Cancer treatment could be replicated for COVID-19
Australian research at centre of landmark treatment trial for COVID-19
‘Genome Archeologists’ at University and UHN activate immune response against cancer
Partial immunity and social distancing could reduce COVID-19 mortality rates
Cancer researcher to tackle high rates of relapse after sarcoma surgery
University researchers discover mechanism linking gum disease to heart disease, other conditions
Protein by which common skin bacteria trigger eczema identified
‘Multi-omics’ adds new cell to immune family tree
No genetic signs that hearing loss causes Alzheimer’s disease
Blood test could identify COVID-19 patients at risk of ‘cytokine storm’ hyperinflammation
Funding allows researchers to uncover secrets of COVID-19 immunity
Clinical study aims to better understand COVID-19 immunity
Professor Stephen Holgate receives Knighthood in Queen’s Birthday Honours List
Kirby Institute awarded over $7m for HIV, hepatitis C and COVID-19 immunology research
Potential COVID-19 vaccines not affected by dominant ‘G-strain’
COVID-19 outcomes in patients with rare inborn immune disord
IL-21 protein a key part of immune response to central nervous system infections